H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $13.00 price target on Fennec Pharmaceuticals Inc. (NASDAQ: FENC).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments